Julien Hadoux
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.
Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.
Journal: Journal of visceral surgery
Published: August 11, 2026
Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility.
Journal: Endocrine-related cancer
Published: March 25, 2026
Hepatic arterial embolization procedures in neuroendocrine tumors with carcinoid heart disease: a retrospective single-center study on safety and feasibility.
Journal: Endocrine-related cancer
Published: March 25, 2026
Cabozantinib - unresectable or metastatic well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors after at least one prior line of systemic therapy other than somatostatin analogues
Journal: Bulletin du cancer
Published: March 10, 2026
European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents.
Journal: Pediatric blood & cancer
Published: January 11, 2026
Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort study.
Journal: The lancet. Diabetes & endocrinology
Published: November 13, 2025
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: November 04, 2025
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.
Journal: Thyroid : official journal of the American Thyroid Association
Published: October 29, 2025
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET.
Journal: ESMO open
Published: September 16, 2025
French expert consensus statement on diagnosis and management of primary hyperparathyroidism.
Journal: Annales d'endocrinologie
Published: September 01, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 19, 2025
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 13, 2025
Last Updated: 09/26/2026